Author/Authors :
Shahbazian، H.B نويسنده Endocrine Department, Golestan Hospital, Ahwaz Jundishapur University of Medical Sciences Shahbazian, H.B , Amani ، R نويسنده School of Paramedical Sciences, Ahwaz Jundishapur University of Medical Sciences Amani , R , Siadatan، J نويسنده Endocrine Department, Golestan Hospital, Ahwaz Jundishapur University of Medical Sciences Siadatan, J , Shahbazian ، H نويسنده Endocrine Department, Golestan Hospital, Ahwaz Jundishapur University of Medical Sciences Shahbazian , H , Latifi ، M نويسنده School of Health, Ahwaz Jundishapur University of Medical Sciences Latifi , M , Ahmadzadeh، A نويسنده Endocrine Department, Golestan Hospital, Ahwaz Jundishapur University of Medical Sciences Ahmadzadeh, A , Haghighizadeh ، M نويسنده School of Health, Ahwaz Jundishapur University of Medical Sciences Haghighizadeh , M
Abstract :
uncontrolled diabetes, participated in this study. They completed a trial of dietary supplementation with 25gr/day of a processed defeated meal containing 12 gr soyprotein and about 50mg isoflavones, for 3 months. FBS, HbA1C, serum total cholesterol, triglyceride, HDL and LDL-C and patients non-diabetic subjects. The purpose of this study was to evaluate if a dietary soyprotein isoflavones affects lipid and blood glucose levels in type 2 diabetic subjects. Twenty six type, weight and blood pressure were checked before soyprotein consumption and monthly thereafter. There were significant differences in mean FBS (153?50 versus 178?60, P < 0.015), HbA1C (8.8 ? 1.4 versus 9.6 ? 1.7 percent, P < 0.001), triglycerides concentration (229 ? 113 versus 267 ? 149 P < 0.008) and total cholesterol (196 ? 41 versus 207 ? 42, P < 0.002) before and after three months consumption of soyprotein isoflavones.There were Consumption of soyprotein has recently been shown to improve the blood lipid levels in no significant changes in HDL and LDL-C cholesterol levels, blood pressure and weight.
